Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Xaar plc is a public company specializing in the design, manufacture, and supply of industrial inkjet printheads and related technologies, headquartered in Cambridge, UK. Founded in 1990 from an inkjet research project, it focuses on piezo-electric printhead innovations for diverse applications including ceramic tile decoration, coding and marking, wide-format graphics, packaging, labels, product printing, and advanced manufacturing sectors like 3D printing, printed electronics, and semiconductors. Notable products include the high-resolution Xaar 2002 at 720 dpi, high-frequency Xaar Nitrox, and Xaar Irix for precise fluid deposition. Through subsidiaries like Engineered Printing Solutions (EPS), it offers customized print systems for marking industrial objects such as medical equipment, automotive parts, and promotional items. Additional units provide digital imaging solutions via FFEI and ink supply systems. Xaar plc supports OEMs and user developers with integrated ecosystems including drive electronics, fluids, and development kits, playing a key role in advancing digital inkjet efficiency, precision, and versatility across global industrial markets.
£1.21
+£0.02 (+1.26%)
EOD Jul 3, 2026
Operating margin is thin at 1.91%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 11.7% YoY with margins expanding 3.0pp. However, free cash flow softened 121%, worth monitoring whether this is timing or structural.
Free cash flow declined 121% versus the prior year, cash generation momentum has weakened. Negative free cash flow of -£1M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£60M
▲ +11.7% YoY
Net Income (TTM)
-£3M
▲ +68.7% YoY
Op. Margin
1.91%
▲ +3.0pp YoY
ROIC
1.42%
▲ +2.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-£1M
▼ -121.0% YoY
Op. Cash Flow (TTM)
£775K
▼ -88.1% YoY
Net Debt
-£2M
Net Cash Position
Cash & Equiv.
£7M
3Y CAGR: -6.2%
Continue Research
Xaar (XAR.XLON)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Xaar scores 30/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Xaar scores 30 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 1.9% operating margin and a 1.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh XAR.XLON's valuation and scores 30/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.